Doxorubicin delivery enhanced by electroporation to gastrointestinal adenocarcinoma cells with P-gp overexpression

Bioelectrochemistry

Volumn 100, Issue , 2014, Pages 96-104

  Kulbacka, Julita ^a   Daczewska, Małgorzata ^b   Dubińska Magiera, Magda ^b   Choromańska, Anna ^a   Rembiałkowska, Nina ^a   Surowiak, Paweł ^a   Kulbacki, Marek ^c   Kotulska, Małgorzata ^d   Saczko, Jolanta ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b UNIVERSITY OF WROC AW   (Poland)

^c POLISH JAPANESE INSTITUTE OF INFORMATION TECHNOLOGY   (Poland)

^d WROCLAW UNIVERSITY OF TECHNOLOGY   (Poland)

Author keywords

Adenocarcinoma treatment; Doxorubicin; Electrochemotherapy; Electropermeabilization; Electroporation

Indexed keywords

ADENOCARCINOMA TREATMENT; DOXORUBICIN; ELECTROCHEMOTHERAPY; ELECTROPERMEABILIZATION; ELECTROPORATION;

DOXORUBICIN; MULTIDRUG RESISTANCE PROTEIN; ANTINEOPLASTIC AGENT;

ADENOCARCINOMA CELL LINE; ANIMAL CELL; ARTICLE; CELL ULTRASTRUCTURE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG TRANSPORT; ELECTROMAGNETIC FIELD; ELECTROPORATION; GASTROINTESTINAL CARCINOMA; HUMAN; HUMAN CELL; MACROMOLECULE; MITOCHONDRION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; TRANSMISSION ELECTRON MICROSCOPY; TRYPAN BLUE ASSAY; ADENOCARCINOMA; ANIMAL; CELL SURVIVAL; COLON TUMOR; DRUG EFFECTS; GENE EXPRESSION REGULATION; IMMUNOLOGY; MACROPHAGE; METABOLISM; MULTIDRUG RESISTANCE; PATHOLOGY; PROCEDURES; STOMACH TUMOR; TUMOR CELL LINE;

ADENOCARCINOMA; ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL SURVIVAL; COLONIC NEOPLASMS; DOXORUBICIN; DRUG DELIVERY SYSTEMS; DRUG RESISTANCE, MULTIPLE; ELECTROPORATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MACROPHAGES; MICE; P-GLYCOPROTEIN; STOMACH NEOPLASMS;

EID: 84908077643     PISSN: 15675394     EISSN: 1878562X     Source Type: Journal    
DOI: 10.1016/j.bioelechem.2014.03.013     Document Type: Article

References (39)

1. Drag M., Surowiak P., Drag-Zalesinska M., Dietel M., Lage H., Oleksyszyn J. Comparison of the cytotoxic effects of birch bark extract, betulin and betulinic acid towards human gastric carcinoma and pancreatic carcinoma drug-sensitive and drug-resistant cell lines. Molecules 2009, 14:1639-1651.
2. Lage H. ABC-transporters: implications on drug resistance from microorganisms to human cancers. Int. J. Antimicrob. Agents 2003, 22:188-199.
3. Tang B., Li L., Jiang Z., Luan Y., Li D., Zhang W., Reed E., Li Q.Q. Characterization of the mechanisms of electrochemotherapy in an in vitro model for human cervical cancer. Int. J. Oncol. 2005, 26(3):703-711.
4. Pakhomova O.N., Gregory B.W., Pakhomov A.G. Facilitation of electroporative drug uptake and cell killing by electrosensitization. J. Cell. Mol. Med. 2013, 17(1):154-159.
5. Kotulska M., Kulbacka J., Saczko J. Advances in photodynamic therapy assisted by electroporation. Curr. Drug Metab. 2013, 14(3):309-318.
6. Sauer H., Pütz V., Fischer K., Hescheler J., Wartenberg M. Increased doxorubicin uptake and toxicity in multicellular tumour spheroids treated with DC electrical fields. Br. J. Cancer 1999, 80(8):1204-1213.
7. Sersa G., Cemazar M., Miklavcic D. Antitumor effectiveness of electrochemotherapy with cis-diamminedichloroplatinum (II) in mice. Cancer Res. 1995, 55:3450-3455.
8. Mir L.M., Devauchelle P., Quintin-Colonna F., Delisle F., Dolinger S., Fradelizi D., Belehradek J., Orlowski S. First clinical trial of cat soft-tissue sarcomas treatment by electrochemotherapy. Br. J. Cancer 1997, 76:1617-1622.
9. Cemazar M., Tamzali Y., Sersa G., Tozon N., Mir L.M., Miklavcic D., Lowe R., Teissie J. Electrochemotherapy in veterinary oncology. J. Vet. Intern. Med. 2008, 22(4):826-831.
10. Benevento R., Santoriello A., Perna G., Canonico S. Electrochemotherapy of cutaneous metastases from breast cancer in elderly patients: a preliminary report. BMC Surg. 2012, 12(Suppl. 1):S6.
11. Mali B., Jarm T., Snoj M., Sersa G., Miklavcic D. Antitumor effectiveness of electrochemotherapy: a systematic review and meta-analysis. Eur. J. Surg. Oncol. 2013, 39(1):4-16.
12. Mali B., Miklavcic D., Campana L.G., Cemazar M., Sersa G., Snoj M., Jarm T. Tumor size and effectiveness of electrochemotherapy. Radiol. Oncol. 2013, 47(1):32-41.
13. Matthiessen L.W., Johannesen H.H., Hendel H.W., Moss T., Kamby C., Gehl J. Electrochemotherapy for large cutaneous recurrence of breast cancer: a phase II clinical trial. Acta Oncol. 2012, 51(6):713-721.
14. Teissié J., Escoffre J.M., Paganin A., Chabot S., Bellard E., Wasungu L., Rols M.P., Golzio M. Drug delivery by electropulsation: recent developments in oncology. Int. J. Pharm. 2012, 423(1):3-6. (14). 10.1016/j.ijpharm.2011.09.038.
15. Sersa G., Cemazar M., Snoj M. Electrochemotherapy of tumours. Curr. Oncol. 2009, 16(2):34-35.
16. Mir L.M. Bases and rationale of the electrochemotherapy. Eur. J. Cancer Suppl. 2006, 4:38-44.
17. Kotulska M. Electrochemotherapy in cancer treatment. Adv. Clin. Exp. Med. 2007, 16(5):601-607.
18. Rols M.P. Electropermeabilization, a physical method for the delivery of therapeutic molecules into cells. Biochim. Biophys. Acta 2006, 1758:423-428.
19. Edhemovic I., Gadzijev E.M., Brecelj E., Miklavcic D., Kos B., Zupanic A., Mali B., Jarm T., Pavliha D., Marcan M., Gasljevic G., Gorjup V., Music M., Vavpotic T.P., Cemazar M., Snoj M., Sersa G. Electrochemotherapy: a new technological approach in treatment of metastases in the liver. Technol. Cancer Res. Treat. 2011, 10(5):475-485.
20. Todorovic V., Sersa G., Flisar K., Cemazar M. Enhanced cytotoxicity of bleomycin and cisplatin after electroporation in murine colorectal carcinoma cells. Radiol. Oncol. 2009, 43(4):264-273.
21. Kulbacka J., Saczko J., Chwiłkowska A. Rak jelita grubego - charakterystyka i oporność na leczenie. Onkol. Prak. Klin. 2008, 4:135-140.
22. Fujihara M., Wakamoto S., Ito T., Muroi M., Suzuki T., Ikeda H., Ikebuchi K. Lipopolysaccharide-triggered desensitization of TNF-α mRNA expression involves lack of phosphorylation of IκBα in a murine macrophage-like cell line, P388D1. J. Leukoc. Biol. 2000, 68(2):267-276.
23. Saczko J., Nowak M., Skołucka N., Kulbacka J., Kotulska M. The effects of the electro-photodynamic in vitro treatment on human lung adenocarcinoma cells. Bioelectrochemistry 2010, 79:90-94.
24. Kulbacka J., Kotulska M., Rembiałkowska N., Choromańska A., Kamińska I., Garbiec A., Rossowska J., Daczewska M., Jachimska B., Saczko J. Cellular stress induced by photodynamic reaction with CoTPPS and MnTMPyPCl(5) in combination with electroporation in human colon adenocarcinoma cell lines (LoVo and LoVoDX). Cell Stress Chaperones 2013, 18:719-731.
25. Interactive 3D surface plot (website). http://rsb.info.nih.gov/ij/plugins/surface-plot-3d.html.
26. Reynolds E. The use of lead citrate at high pH as an electron-opaque stain in electron microscopy. J. Cell Biol. 1963, 17:208-212.
27. Engström P.E., Ivarsson K., Tranberg K.G., Stenram U., Salford L.G., Persson B.R. Electrically mediated drug delivery for treatment of an adenocarcinoma transplanted into rat liver. Anticancer Res. 2001, 21(3B):1817-1822.
28. Entin I., Plotnikov A., Korenstein R., Keisari Y. Tumor growth retardation, cure, and induction of antitumor immunity in B16 melanoma-bearing mice by low electric field-enhanced chemotherapy. Clin. Cancer Res. 2003, 9:3190-3197.
29. Mir L.M., Orlowski S. The basis of electrochemotherapy. Electrochemotherapy, Electrogenetherapy, and Transdermal Drug Delivery. Electrically Mediated Delivery of Molecules to Cells 2000, 99-117. Humana Press, New Jersey. M.J. Jaroszeski, R. Heller, R. Gilbert (Eds.).
30. Meschini S., Condello M., Lista P., Vincenzi B., Baldi A., Citro G., Arancia G., Spugnini E.P. Electroporation adopting trains of biphasic pulses enhances in vitro and in vivo the cytotoxic effect of doxorubicin on multidrug resistant colon adenocarcinoma cells (LoVo). Eur. J. Cancer 2012, 48(14):2236-2243. 10.1016/j.ejca.2011.11.031.
31. Shil P., Kumar A., Vidyasagar P.B., Mishra K.P. Electroporation enhances radiation and doxorubicin-induced toxicity in solid tumor in vivo. J. Environ. Pathol. Toxicol. Oncol. 2006, 25(4):625-632.
32. Suttana W., Mankhetkorn S., Poompimon W., Palagani A., Zhokhov S., Gerlo S., Haegeman G., Berghe W.V. Differential chemosensitization of P-glycoprotein overexpressing K562/Adr cells by withaferin A and Siamois polyphenols. Mol. Cancer 2010, 9:99. 10.1186/1476-4598-9-99.
33. Kambe M., Arita D., Kikuchi H., Funato T., Tezuka F., Gamo M., Murakawa Y., Kanamaru R. Enhancement of the efficacy of anticancer drugs with electroporation: successful electrochemotherapy against gastric cancer cell lines in vivo and in vitro. Int. J. Clin. Oncol. 1997, 2(2):111-117.
34. Campana L.G., Scarpa M., Rossi C.R. Minimally invasive treatment of peristomal metastases from gastric cancer at an ileostomy site by electrochemotherapy. Radiol. Oncol. 2013, 47(4):370-375.
35. Lin R., Shi Ng L., Wang Chi-H. In vitro study of anticancer drug doxorubicin in PLGA-based microparticles. Biomaterials 2005, 26(21):4476-4485.
36. Li T., Wang H., Sun Y., Zhao L., Gang Y., Guo X., Huang R., Yang Z., Pan Y., Wu K., Xu L., Liu Z., Fan D. Transcription factor CUTL1 is a negative regulator of drug resistance in gastric cancer. J. Biol. Chem. 2013, 288(6):4135-4147.
37. Kulbacka J., Chwilkowska A., Bar J., Pola A., Banas T., Gamian A., Saczko J. Oxidative alterations induced in vitro by the photodynamic reaction in doxorubicin-sensitive (LoVo) and -resistant (LoVoDX) colon adenocarcinoma cells. Exp. Biol. Med. (Maywood) 2010, 235(1):98-110.
38. Ye S., MacEachran D.P., Hamilton J.W., O'Toole G.A., Stanton B.A. Chemotoxicity of doxorubicin and surface expression of P-glycoprotein (MDR1) is regulated by the Pseudomonas aeruginosa toxin Cif. Am. J. Physiol. Cell Physiol. 2008, 295(3):C807-C818.
39. Shen F., Chu S., Bence A.K., Bailey B., Xue X., Erickson P.A., Montrose M.H., Beck W.T., Erickson L.C. Quantitation of doxorubicin uptake, efflux, and modulation of multidrug resistance (MDR) in MDR human cancer cells. J. Pharmacol. Exp. Ther. 2008, 324(1):95-102.